CooperCompanies to Present at the J.P. Morgan Healthcare Conference
CooperCompanies (NYSE: COO), a prominent medical device company, has announced its participation in the upcoming J.P. Morgan Healthcare Conference. The company's presentation is scheduled for Tuesday, January 14, 2025, at 6:00 PM ET. Al White, President and CEO, will be representing CooperCompanies at the conference. Interested parties can access both live and archived webcasts of the presentation through the company's investor relations website at http://investor.coopercos.com.
CooperCompanies (NYSE: COO), un'importante azienda nel settore dei dispositivi medici, ha annunciato la sua partecipazione alla prossima J.P. Morgan Healthcare Conference. La presentazione dell'azienda è programmata per martedì 14 gennaio 2025, alle 18:00 ET. Al White, Presidente e CEO, rappresenterà CooperCompanies durante la conferenza. Le parti interessate possono accedere sia alle trasmissioni in diretta che a quelle registrate della presentazione attraverso il sito web delle relazioni con gli investitori dell'azienda all'indirizzo http://investor.coopercos.com.
CooperCompanies (NYSE: COO), una destacada empresa de dispositivos médicos, ha anunciado su participación en la próxima J.P. Morgan Healthcare Conference. La presentación de la empresa está programada para martes, 14 de enero de 2025, a las 6:00 PM ET. Al White, Presidente y CEO, representará a CooperCompanies en la conferencia. Las partes interesadas pueden acceder tanto a las transmisiones en vivo como a las grabadas de la presentación a través del sitio web de relaciones con inversores de la empresa en http://investor.coopercos.com.
CooperCompanies (NYSE: COO), 저명한 의료 기기 회사가 다가오는 J.P. Morgan Healthcare Conference에 참여한다고 발표했습니다. 회사의 발표는 2025년 1월 14일 화요일 오후 6시 ET로 예정되어 있습니다. Al White 대통령 겸 CEO가 컨퍼런스에서 CooperCompanies를 대표합니다. 관심 있는 분들은 회사의 투자자 관계 웹사이트인 http://investor.coopercos.com를 통해 라이브 및 아카이브된 발표 웹캐스트에 접근할 수 있습니다.
CooperCompanies (NYSE: COO), une entreprise médicale de premier plan, a annoncé sa participation à la prochaine J.P. Morgan Healthcare Conference. La présentation de l'entreprise est prévue pour mardi 14 janvier 2025 à 18h00 ET. Al White, Président et CEO, représentera CooperCompanies lors de la conférence. Les parties intéressées peuvent accéder aux webdiffusions en direct et aux enregistrements de la présentation via le site web des relations avec les investisseurs de l'entreprise à l'adresse http://investor.coopercos.com.
CooperCompanies (NYSE: COO), ein prominentes Unternehmen für medizinische Geräte, hat seine Teilnahme an der bevorstehenden J.P. Morgan Healthcare Conference angekündigt. Die Präsentation des Unternehmens ist für Dienstag, den 14. Januar 2025, um 18:00 Uhr ET angesetzt. Al White, Präsident und CEO, wird CooperCompanies auf der Konferenz vertreten. Interessierte Personen können sowohl Live- als auch archivierte Webcasts der Präsentation über die Investoren-Website des Unternehmens unter http://investor.coopercos.com abrufen.
- None.
- None.
SAN RAMON, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, today announced it will participate at the J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025. Al White, President and CEO, will represent the Company in a session scheduled to begin at 6:00 PM ET.
A live and archived webcast of this event, where applicable, will be available by accessing the CooperCompanies’ website at http://investor.coopercos.com.
About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, improving the vision of millions of people every day. CooperSurgical is a leading fertility and women’s health company dedicated to assisting women, babies and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies (“Cooper”) has a workforce of more than 16,000 with products sold in over 130 countries. For more information, please visit www.coopercos.com.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com
FAQ
When is CooperCompanies (COO) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch CooperCompanies' (COO) J.P. Morgan Healthcare Conference presentation?
Who will represent CooperCompanies (COO) at the 2025 J.P. Morgan Healthcare Conference?
Will CooperCompanies' (COO) J.P. Morgan Healthcare Conference presentation be available after the event?
